Department for Plastic Surgery, Institute for Mother and Child Health Care of Serbia Dr. Vukan Cupic, Belgrade, Serbia.
Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
Front Public Health. 2021 Mar 4;9:634778. doi: 10.3389/fpubh.2021.634778. eCollection 2021.
Cardiovascular diseases, including ischemic heart disease, are the most common causes of morbidity and death in the world, including Serbia, as a middle-income European country. The aim of the study was to determine the costs of preventive examinations for ischemic heart disease in active-duty military personnel, as well as to assess whether this was justified from the point of view of the limited health resources allocated for the treatment of the Republic of Serbia population. This is a retrospective cost-preventive study which included 738 male active-duty military personnel, aged from 23 to 58. The costs of primary prevention of ischemic heart disease in this population were investigated. Out of 738 subjects examined, arterial hypertension was detected in 101 subjects (in 74 of them, arterial hypertension was registered for the first time, while 27 subjects were already subjected to pharmacotherapy for arterial hypertension). Average costs of all services during the periodic-health-examination screening program were €76.96 per subject. However, average costs of all services during the periodic-health-examination screening program for patients with newfound arterial hypertension and poorly regulated arterial hypertension were €767.54 per patient and €2,103.63 per patient, respectively. Since periodic-health-examination screening program in military personnel enabled not only discovery of patient with newfound arterial hypertension but also regular monitoring of those who are already on antihypertensive therapy, significant savings of €690.58 per patient and €2,026.67 per patient can be achieved, respectively. As financial resources for providing health care in Serbia, as a middle-income country, are limited, further efforts should be put on screening programs for ischemic heart disease due to possible significant savings.
心血管疾病，包括缺血性心脏病，是世界上包括塞尔维亚在内的中等收入欧洲国家发病率和死亡率最高的疾病。本研究的目的是确定现役军人缺血性心脏病预防检查的费用，并评估从分配给塞尔维亚共和国人口的有限卫生资源的角度来看，这是否合理。这是一项回顾性成本预防研究，其中包括 738 名年龄在 23 至 58 岁的男性现役军人。研究了该人群缺血性心脏病一级预防的费用。在接受检查的 738 名受试者中，发现 101 名受试者患有高血压（其中 74 名受试者首次发现高血压，而 27 名受试者已接受高血压药物治疗）。在定期体检筛查计划中，所有服务的平均费用为每位受试者 76.96 欧元。然而，在定期体检筛查计划中，对于新发现的高血压和控制不佳的高血压患者，所有服务的平均费用分别为每位患者 767.54 欧元和每位患者 2103.63 欧元。由于定期体检筛查计划不仅可以发现新发现的高血压患者，还可以定期监测已经接受抗高血压治疗的患者，因此可以分别节省每位患者 690.58 欧元和每位患者 2026.67 欧元。由于塞尔维亚等中等收入国家提供医疗保健的财政资源有限，因此应进一步努力开展缺血性心脏病筛查计划，以实现可能的显著节省。
